These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 11362869

  • 1. Agouron protease inhibitor.
    AIDS Treat News; 1995 Sep 29; (no 231):5. PubMed ID: 11362869
    [Abstract] [Full Text] [Related]

  • 2. Agouron protease inhibitor AG1343: activity reported.
    James JS.
    AIDS Treat News; 1995 May 05; (no 222):6. PubMed ID: 11362464
    [Abstract] [Full Text] [Related]

  • 3. Protease inhibitors at Retroviruses Conference: Agouron's results.
    James JS.
    AIDS Treat News; 1996 Mar 01; (no 242):5-6. PubMed ID: 11363194
    [Abstract] [Full Text] [Related]

  • 4. Nelfinavir (Viracept) moves up the ranks.
    Grodeck B.
    Posit Aware; 1997 Mar 01; 8(2):16-7. PubMed ID: 11364452
    [Abstract] [Full Text] [Related]

  • 5. The next wave of protease inhibitors.
    Smart T.
    GMHC Treat Issues; 1995 Jun 01; 9(6):4. PubMed ID: 11362690
    [Abstract] [Full Text] [Related]

  • 6. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug 01; 13(72):144-50. PubMed ID: 15532140
    [Abstract] [Full Text] [Related]

  • 7. Clinical potential of a new HIV protease inhibitor.
    Chapman S, Peterkin J, Quart B, Youle M.
    J Int Assoc Physicians AIDS Care; 1995 Jun 01; 1(5):24. PubMed ID: 11362604
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nelfinavir - major trial results at retroviruses conference.
    AIDS Treat News; 1997 Feb 21; (No 265):3-4. PubMed ID: 11364240
    [Abstract] [Full Text] [Related]

  • 10. Nelfinavir (Viracept) expanded access announced.
    AIDS Treat News; 1996 Sep 20; (No 255):4. PubMed ID: 11363837
    [Abstract] [Full Text] [Related]

  • 11. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA, Akinsete L, Abalaka AD, Keshinro LB, Dutse L, Onyenekwe B, Lhekwaba A, Njoku OS, Kehinde MO, Wambebe CO.
    West Afr J Med; 2002 Sep 20; 21(2):83-6. PubMed ID: 12403023
    [Abstract] [Full Text] [Related]

  • 12. More clinical data on protease inhibitors.
    Smart T.
    GMHC Treat Issues; 1995 Oct 20; 9(10):4-7. PubMed ID: 11362917
    [Abstract] [Full Text] [Related]

  • 13. Protease inhibitor update.
    Colvin R, Haas G.
    Common Factor; 1995 Apr 20; (no 10):15. PubMed ID: 11362340
    [Abstract] [Full Text] [Related]

  • 14. ABT-538 increases CD4 counts.
    Posit Aware; 1995 Apr 20; ():4. PubMed ID: 11362207
    [Abstract] [Full Text] [Related]

  • 15. Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection.
    Hoffmann F, Funk M, Linde R, Notheis G, Petropoulou T, Eberle J, Gürtler L, Belohradsky BH, Wintergerst U.
    Eur J Med Res; 2002 Jul 24; 7(7):330-4. PubMed ID: 12176683
    [Abstract] [Full Text] [Related]

  • 16. Newly approved PI provides treatment options.
    AIDS Alert; 1997 Jun 24; 12(6):68-9. PubMed ID: 11364360
    [Abstract] [Full Text] [Related]

  • 17. New drug approved to treat HIV.
    Treat Rev; 1997 Apr 24; (No 24):5. PubMed ID: 11364284
    [Abstract] [Full Text] [Related]

  • 18. Closing the circle on HIV--or not.
    Mascolini M.
    J Int Assoc Physicians AIDS Care; 1995 Oct 24; 1(9):10-4, 17-29 contd. PubMed ID: 11362964
    [Abstract] [Full Text] [Related]

  • 19. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
    Resino S, Larrú B, Maria Bellón J, Resino R, de José MI, Navarro M, Léon JA, Ramos JT, Mellado MJ, Muñoz-Fernández MA.
    BMC Infect Dis; 2006 Jul 11; 6():107. PubMed ID: 16834769
    [Abstract] [Full Text] [Related]

  • 20. Two studies show Kaletra and Isentress similarly suppress HIV, yet have different side effects.
    Proj Inf Perspect; 2009 Mar 11; (48):6. PubMed ID: 19492458
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.